Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis ; volume:7 ; number:1 ; day:27 ; month:9 ; year:2017 ; pages:1-12 ; date:12.2017
Scientific reports ; 7, Heft 1 (27.9.2017), 1-12, 12.2017
- Urheber
-
Ryaboshapkina, Maria
Hammar, Mårten
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-017-10930-w
- URN
-
urn:nbn:de:101:1-2019102018313625376633
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ryaboshapkina, Maria
- Hammar, Mårten
- SpringerLink (Online service)
Ähnliche Objekte (12)
Non-alcoholic fatty liver disease
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management
Non-alcoholic fatty liver disease
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management
Non-alcoholic fatty liver disease
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)